MMIT is an investment company that offers a high conviction portfolio of 20-30 smaller companies across emerging and frontier markets. Managed by seasoned emerging market investors Mark Mobius and Carlos Hardenberg, the company actively seeks to differentiate itself from broader emerging market benchmarks, with a heavy weighting towards high technology and healthcare businesses.

In this interview we speak to Carlos Hardenberg about why the company’s strategy is to target profitable and innovative mid-cap companies in emerging markets; the deep investigative process behind stock selection, which includes screening for quality factors, economic moats, and entrepreneurial management; why bottom up analysis needs to be overlaid with a robust view of macroeconomic factors; why emerging markets no longer deserve their reputation as being higher risk vis-à-vis developed markets, and their underappreciated global potential in technology industries; and why the trust favours India and other emerging Asian regions over China.